Extract from the Register of European Patents

EP About this file: EP4192547

EP4192547 - DRIVE ARRANGEMENT FOR A DRUG DELIVERY DEVICE [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  01.08.2025
Database last updated on 28.03.2026
FormerRequest for examination was made
Status updated on  12.05.2023
FormerThe international publication has been made
Status updated on  11.02.2022
Formerunknown
Status updated on  30.08.2021
Most recent event   Tooltip31.01.2026New entry: Reply to examination report 
Applicant(s)For all designated states
Sanofi
46 avenue de la Grande Armée
75017 Paris / FR
[2023/24]
Inventor(s)01 / DASBACH, Uwe
65926 Frankfurt am Main / DE
02 / KEMP, Thomas Mark
Melbourn Hertfordshire SG8 6DP / GB
03 / CORREA, Tomas
Melbourn Hertfordshire SG8 6DP / GB
 [2023/24]
Representative(s)Schmidt, Christian
ZSP Patentanwälte PartG mbB
Hansastraße 32
80686 München / DE
[2023/24]
Application number, filing date21758080.203.08.2021
[2023/24]
WO2021EP71606
Priority number, dateEP2020031538007.08.2020         Original published format: EP 20315380
[2023/24]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2022029095
Date:10.02.2022
Language:EN
[2022/06]
Type: A1 Application with search report 
No.:EP4192547
Date:14.06.2023
Language:EN
The application published by WIPO in one of the EPO official languages on 10.02.2022 takes the place of the publication of the European patent application.
[2023/24]
Search report(s)International search report - published on:EP10.02.2022
ClassificationIPC:A61M5/20, A61M5/315, A61M5/32, A61M5/31
[2023/24]
CPC:
A61M5/2033 (EP,US); A61M5/3146 (EP,US); A61M5/31505 (EP,US);
A61M5/326 (EP,US); A61M2005/2013 (EP); A61M2005/3267 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/24]
TitleGerman:ANTRIEBSANORDNUNG FÜR EINE ARZNEIMITTELABGABEVORRICHTUNG[2023/24]
English:DRIVE ARRANGEMENT FOR A DRUG DELIVERY DEVICE[2023/24]
French:SYSTÈME D'ENTRAÎNEMENT POUR DISPOSITIF D'ADMINISTRATION DE MÉDICAMENT[2023/24]
Entry into regional phase03.03.2023National basic fee paid 
03.03.2023Designation fee(s) paid 
03.03.2023Examination fee paid 
Examination procedure03.03.2023Amendment by applicant (claims and/or description)
03.03.2023Examination requested  [2023/24]
03.03.2023Date on which the examining division has become responsible
05.08.2025Despatch of a communication from the examining division (Time limit: M06)
30.01.2026Reply to a communication from the examining division
Fees paidRenewal fee
14.06.2023Renewal fee patent year 03
12.06.2024Renewal fee patent year 04
13.06.2025Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XDI] EP2583708  (SHL GROUP AB et al.)
 [XDI] EP3458128  (SHL MEDICAL AG et al.) [XD] 1-11,13-15 * figures 1b, 1c, 2a, 3, 4c, 5 * * paragraphs [0029] , [0 31] , [0 33] , [ 38] , [0 40] , [0 52] , [0 53] *[I] 12
 [X] US2018214637  (KEMP THOMAS MARK et al.) [X] 1-15 * figures 5, 6, 7, 8, 9a * * paragraphs [0029] , [0 30] , [0 41] , [0 42] , [0 43] , [0 44] , [0 48] , [0 49] , [0 51] *
by applicantEP2583708
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.